Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-025492
Filing Date
2025-05-14
Accepted
2025-05-14 16:11:03
Documents
52
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q advm-20250331.htm   iXBRL 10-Q 1025920
2 EX-31.1 advm-20250331ex311.htm EX-31.1 10084
3 EX-31.2 advm-20250331ex312.htm EX-31.2 10105
4 EX-32.1 advm-20250331ex321.htm EX-32.1 5343
5 EX-32.2 advm-20250331ex322.htm EX-32.2 5341
  Complete submission text file 0001628280-25-025492.txt   4204435

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT advm-20250331.xsd EX-101.SCH 22942
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT advm-20250331_cal.xml EX-101.CAL 47130
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT advm-20250331_def.xml EX-101.DEF 93792
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT advm-20250331_lab.xml EX-101.LAB 415803
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT advm-20250331_pre.xml EX-101.PRE 260747
55 EXTRACTED XBRL INSTANCE DOCUMENT advm-20250331_htm.xml XML 371625
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36579 | Film No.: 25945585
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)